WPI 1119 (Mirtazapine 45 mg)

Pill imprint WPI 1119 has been identified as Mirtazapine 45 mg.

Mirtazapine is used in the treatment of depression; insomnia; anxiety; post traumatic stress disorder; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WPI 1119 (Mirtazapine 45 mg)

Mirtazapine 45 mg WPI 1119
Mirtazapine
Imprint:
WPI 1119
Strength:
45 mg
Color:
White
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Tetracyclic antidepressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-1119
Inactive Ingredients:
lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
16590-0155 Stat RX USA LLC (repackager)
58016-0282 Southwood Pharmaceuticals Inc (repackager)
63874-1155 Altura Pharmaceuticals Inc (repackager)
68258-7006 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)